Back
JPMorgan Chase & Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
64
JPM
JPMorgan Chase &
Last Price:
201.46
Seasonality Move:
-0.74%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
158.02
Seasonality Move:
18.65%
Buy
64
JPMorgan Chase & (JPM)
is a Buy
Is JPMorgan Chase & a Buy, Sell or Hold?
- The current JPMorgan Chase & [JPM] share price is $199.17. The Score for JPM is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- JPM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $157.96. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JPM Stock Price Chart
What is JPMorgan Chase &'s stock price today?
-
The JPMorgan Chase & share price today is $199.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JPM is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $157.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
JPM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.27 | Buy |
Relative Strength Index (14 RSI): | 54.23 | Buy |
Chaikin Money Flow: | 4176917 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (195.2 - 200.32) | Buy |
Bollinger Bands (100): | (183.95 - 199.69) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.07 | Buy |
Relative Strength Index (14 RSI): | 68.93 | Buy |
Chaikin Money Flow: | 909555 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (113.85 - 144.93) | Buy |
Bollinger Bands (100): | (118.68 - 136.96) | Buy |
JPM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 197.56 | Buy |
20-day SMA: | 197.53 | Buy |
50-day SMA: | 195.84 | Buy |
200-day SMA: | 173.64 | Buy |
8-day EMA: | 197.67 | Buy |
20-day EMA: | 197.34 | Buy |
50-day EMA: | 195.66 | Buy |
200-day EMA: | 178.14 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 144.42 | Buy |
20-day SMA: | 131.3 | Buy |
50-day SMA: | 128.76 | Buy |
200-day SMA: | 115.64 | Buy |
8-day EMA: | 148.13 | Buy |
20-day EMA: | 137 | Buy |
50-day EMA: | 130.51 | Buy |
200-day EMA: | 121.04 | Buy |
JPMorgan Chase & Earnings Growth & JPM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.22 per share, a decrease this year of $0.58 per share, and an increase next year of $0.28 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
JPMorgan Chase & Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |